The synthesis of symmetrical and unsymmetrical P1/P1′ cyclic ureas as HIV protease inhibitors

被引：28
|
作者：
Patel, M
Kaltenbach, RF
Nugiel, DA
McHugh, RJ
Jadhav, PK
Bacheler, LT
Cordova, BC
Klabe, RM
Erickson-Viitanen, S
Garber, S
Reid, C
Seitz, SP
机构：
[1] Dupont Merck Pharmaceut Co, Expt Stn, Dept Chem & Phys Sci, Wilmington, DE 19880 USA
[2] Dupont Merck Pharmaceut Co, Expt Stn, Dept Virol, Wilmington, DE 19880 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 09期
关键词：
D O I：
10.1016/S0960-894X(98)00175-9
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Cyclic urea SD146, a potent HIV protease inhibitor bearing a flat resistance profile, possessed poor solubility and bioavailability, which precluded further development of the compound. In an effort to improve upon the pharmacokinetic profile of the compound, several analogs modified at the P1/P1' residues were prepared and evaluated. Several of those compounds displayed significant improvement of physical properties. (C) 1998 The DuPont Merck Pharmaceutical Company. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：1077 / 1082
页数：6
相关论文
共 50 条
  • [1] The synthesis and evaluation of cyclic ureas as HIV protease inhibitors:: Modifications of the P1/P1′ residues
    Patel, M
    Bacheler, LT
    Rayner, MM
    Cordova, BC
    Klabe, RM
    Erickson-Viitanen, S
    Seitz, SP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (07) : 823 - 828
  • [2] Increased antiviral activity of cyclic urea HIV protease inhibitors by modifying the P1/P1′ substituents
    Kaltenbach, RF
    Klabe, RM
    Cordova, BC
    Seitz, SP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (15) : 2259 - 2262
  • [3] Synthesis, antiviral activity and pharmacokinetics of P1/P1′ substituted 3-aminoindazole cyclic urea HIV protease inhibitors
    Kaltenbach, RF
    Patel, M
    Waltermire, RE
    Harris, GD
    Stone, BRP
    Klabe, RM
    Garber, S
    Bacheler, LT
    Cordova, BC
    Logue, K
    Wright, MR
    Erickson-Viitanen, S
    Trainor, GL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (04) : 605 - 608
  • [4] Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2′ to P1/P1′
    Ax, A
    Schaal, W
    Vrang, L
    Samuelsson, B
    Hallberg, A
    Karlén, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (03) : 755 - 764
  • [5] Synthesis and antiviral activity of P1′ arylsulfonamide azacyclic urea HIV protease inhibitors
    Huang, PP
    Randolph, JT
    Klein, LL
    Vasavanonda, S
    Dekhtyar, T
    Stoll, VS
    Kempf, DJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) : 4075 - 4078
  • [6] Novel inhibitors of HIV protease: Design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffolds
    Spaltenstein, A
    Almond, MR
    Bock, WJ
    Cleary, DG
    Furfine, ES
    Hazen, RJ
    Kazmierski, WM
    Salituro, FG
    Tung, RD
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (11) : 1159 - 1162
  • [7] The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: Modifications of the P-1/P-1' residues
    Patel, M
    Seitz, SP
    Bacheler, LT
    Rayner, MM
    Cordova, BC
    Meek, JL
    EricksonViitanen, S
    Han, Q
    Lam, PYS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 23 - MEDI
  • [8] Improved P1/P1' substituents for cyclic urea based HIV-1 protease inhibitors: Synthesis, structure-activity relationship, and x-ray crystal structure analysis
    Nugiel, DA
    Jacobs, K
    Cornelius, L
    Chang, CH
    Jadhav, PK
    Holler, ER
    Klabe, RM
    Bacheler, LT
    Cordova, B
    Garber, S
    Reid, C
    Logue, KA
    GoreyFeret, LJ
    Lam, GN
    EricksonViitanen, S
    Seitz, SP
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (10) : 1465 - 1474
  • [9] P1/P1′-modified benzothiadiazepines as metalloproteinase inhibitors.
    Cherney, RJ
    Maeyer, DT
    Wang, L
    Duan, JJW
    Chen, LH
    Arner, EC
    Jaffe, BD
    Covington, MB
    Decicco, CP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U940 - U940
  • [10] P1/P1′ modified HIV protease inhibitors as tools in two new sensitive surface plasmon resonance biosensor screening assays
    Alterman, M
    Sjöbom, H
    Säfsten, P
    Markgren, PO
    Danielson, UH
    Hämäläinen, M
    Löfås, S
    Hultén, J
    Classon, B
    Samuelsson, B
    Hallberg, A
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) : 203 - 212
12345